OnKure Therapeutics, Inc. (OKUR)

OnKure Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	59.05	110.76	29.88	19.93	124.66
Short-Term Investments	-	-	-	81.25	23.01
Cash & Short-Term Investments	59.05	110.76	29.88	101.17	147.67
Cash Growth	-46.69%	270.74%	-70.47%	-31.49%	175.44%
Other Current Assets	1.79	2.24	3.89	5.18	6.06
Total Current Assets	60.84	113	33.77	106.35	153.73
Net Property, Plant & Equipment	1.01	1.8	1.91	1.75	0.21
Other Long-Term Assets	0.27	0.11	0.06	0.08	0.08
Total Assets	62.12	114.91	35.73	108.18	154.02
Accounts Payable	1.43	2.97	3.42	1.89	2.02
Accrued Expenses	3.94	7.03	3.66	4.83	4.18
Current Portion of Leases	0.55	0.54	0.21	0.4	-
Total Current Liabilities	5.92	10.53	7.29	7.12	6.2
Long-Term Leases	-	0.55	0.47	1.06	0.17
Other Long-Term Liabilities	0.01	-	-	0.03	0.44
Total Long-Term Liabilities	0.01	0.55	0.47	1.09	0.61
Total Liabilities	5.93	11.08	7.75	8.21	6.81
Preferred Stock	-	-	129.83	-	-
Common Stock	0	0	-	0	0
Additional Paid-in Capital	270.42	258.55	0.21	236.69	231.9
Accumulated Other Comprehensive Income	-	-	-	-0.04	0.03
Retained Earnings	-214.24	-154.72	-102.05	-136.68	-84.73
Shareholders' Equity	56.18	103.83	-101.84	99.97	147.21
Total Liabilities & Equity	62.12	114.91	35.73	108.18	154.02
Total Debt	0.55	1.09	0.67	1.46	0.17
Net Cash (Debt)	58.5	109.68	29.2	99.71	147.5
Net Cash Growth	-46.66%	275.58%	-70.71%	-32.40%	175.13%
Net Cash Per Share	4.33	31.82	102.89	40.70	81.30
Book Value	56.18	103.83	-101.84	99.97	147.21
Book Value Per Share	4.16	30.12	-358.83	40.81	81.14
Tangible Book Value	56.18	103.83	-101.84	99.97	147.21
Tangible Book Value Per Share	4.16	30.12	-358.83	40.81	81.14

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q